Annual CAPEX
$2000.00
-$7000.00-77.78%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual capital expenditures is $2000.00, with the most recent change of -$7000.00 (-77.78%) on December 31, 2023.
- During the last 3 years, CANF annual CAPEX has fallen by -$24.00 thousand (-92.31%).
- CANF annual CAPEX is now -95.58% below its all-time high of $45.30 thousand, reached on December 31, 2015.
Performance
CANF CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
June 30, 2024
Summary
- CANF quarterly capital expenditures is not available.
Performance
CANF Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
June 30, 2024
Summary
- CANF TTM capital expenditures is not available.
Performance
CANF TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CANF CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -77.8% | - | - |
| 3 y3 years | -92.3% | - | - |
| 5 y5 years | -93.9% | - | - |
CANF CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.8% | at low | ||||
| 5 y | 5-year | -92.3% | at low | ||||
| alltime | all time | -95.6% | at low |
Can-Fite BioPharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $2000.00(-77.8%) | - | - |
| Dec 2022 | $9000.00(-18.2%) | - | - |
| Dec 2021 | $11.00 K(-57.7%) | - | - |
| Dec 2020 | $26.00 K(+766.7%) | - | - |
| Dec 2019 | $3000.00(-90.9%) | - | - |
| Dec 2018 | $33.00 K(+371.4%) | - | - |
| Dec 2017 | $7000.00(-30.0%) | - | - |
| Dec 2016 | $10.00 K(-77.9%) | - | - |
| Dec 2015 | $45.30 K(+376.8%) | - | - |
| Dec 2014 | $9500.00(-22.8%) | - | - |
| Dec 2013 | $12.30 K | $600.00(-72.7%) | $12.40 K(-4.6%) |
| Sep 2013 | - | $2200.00(-12.0%) | $13.00 K(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $2500.00(-64.8%) | $10.80 K(-6.9%) |
| Mar 2013 | - | $7100.00(+491.7%) | $11.60 K(+157.8%) |
| Dec 2012 | $4600.00(-78.4%) | - | - |
| Dec 2012 | - | $1200.00(>+9900.0%) | $4500.00(-2.2%) |
| Sep 2012 | - | $0.00(-100.0%) | $4600.00(-69.9%) |
| Jun 2012 | - | $3300.00(+153.8%) | $15.30 K(-28.2%) |
| Dec 2011 | $21.30 K(-29.5%) | - | - |
| Dec 2011 | - | $1300.00(-87.9%) | $21.30 K(+6.5%) |
| Sep 2011 | - | $10.70 K(+154.8%) | $20.00 K(+115.1%) |
| Jun 2011 | - | $4200.00(-17.6%) | $9300.00(+82.4%) |
| Mar 2011 | - | $5100.00 | $5100.00 |
| Dec 2010 | $30.20 K | - | - |
FAQ
- What is Can-Fite BioPharma annual capital expenditures?
- What is the all time high annual CAPEX for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Can-Fite BioPharma?
- What is the all time high TTM CAPEX for Can-Fite BioPharma?
What is Can-Fite BioPharma annual capital expenditures?
The current annual CAPEX of CANF is $2000.00
What is the all time high annual CAPEX for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual capital expenditures is $45.30 K
What is Can-Fite BioPharma annual CAPEX year-on-year change?
Over the past year, CANF annual capital expenditures has changed by -$7000.00 (-77.78%)
What is the all time high quarterly CAPEX for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly capital expenditures is $10.70 K
What is the all time high TTM CAPEX for Can-Fite BioPharma?
Can-Fite BioPharma all-time high TTM capital expenditures is $21.30 K